✦ LIBER ✦

Genetic variants in germline TP53 and MDM2 SNP309 are not associated with early onset colorectal cancer

✍ Scribed by Sajid A. Khan; Kamran Idrees; Ann Forslund; Zhaoshi Zeng; Shoshana Rosenberg; Hanna Pincas; Francis Barany; Kenneth Offit; Michael P. LaQuaglia; Philip B. Paty

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 120 KB
Volume: 97
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.20996

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetic polymorphisms in cell cycle regu

Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer

✍ Xuemei Zhang; Xiaoping Miao; Yongli Guo; Wen Tan; Yifeng Zhou; Tong Sun; Yonggan 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

The tumor suppressor TP53 pathway plays a crucial role in preventing carcinogenesis through its ability to impose cell cycle arrest and apoptosis following DNA damage and oncogene activation. MDM2 is a key negative regulator of the TP53 pathway and is overexpressed in many cancers as oncoprotein. We

MDM2 SNP309 T>G alone or in combination

MDM2 SNP309 T>G alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients

✍ Bente A. Talseth; Cliff Meldrum; Janina Suchy; Grzegroz Kurzawski; Jan Lubinski; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 64 KB 👁 1 views

## Abstract Disease expression in hereditary nonpolyposis colorectal cancer (HNPCC) cannot be readily explained by mutation site in the respective DNA mismatch repair genes associated with this disorder. One explanation is the role of modifying genes that can either promote or prevent disease devel